E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • J Neuroinfect Dis 2024, Vol 15(2): 2
  • DOI: 10.4172/2314-7326.1000499

Neuropsychiatry: Towards a Philosophy of Praxis

Calaudio Soares*
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Canada
*Corresponding Author: Calaudio Soares, Department of Psychiatry and Behavioural Neurosciences, McMaster University, Canada, Email: c.s8877@gmail.com

Received: 01-Mar-2024 / Manuscript No. JNID-24-130969 / Editor assigned: 04-Mar-2024 / PreQC No. JNID-24-130969 / Reviewed: 18-Mar-2024 / QC No. JNID-24-130969 / Revised: 25-Mar-2024 / Manuscript No. JNID-24-130969 / Published Date: 29-Mar-2024 DOI: 10.4172/2314-7326.1000499 QI No. / JNID-24-130969

Abstract

Neuropsychiatry, the interdisciplinary field at the intersection of neurology and psychiatry, has evolved significantly over the past century. From its early roots in understanding the biological basis of mental disorders to its current endeavors in personalized medicine and translational research, neuropsychiatry has embraced a holistic approach towards understanding the intricate relationship between the brain and behavior. In this review, we explore the historical foundations, current trends, and future directions of neuropsychiatry, emphasizing the need for a philosophy of praxis—a dynamic framework that integrates theory with practical application—to guide research and clinical practice in this burgeoning field.

Keywords

Neuropsychiatry; Philosophy; Praxis; Brain-mind connection; Integrative approach; Clinical neuroscience

Introduction

Neuropsychiatry, a discipline born out of the recognition that mental phenomena are deeply intertwined with brain function, has undergone remarkable transformations since its inception. Initially rooted in anatomical studies and neuropathological observations, neuropsychiatry has expanded its horizons to encompass a broad spectrum of disciplines, including neuroimaging, genetics, pharmacology, and psychotherapy. This interdisciplinary nature reflects the complexity of mental disorders and underscores the importance of adopting a multifaceted approach towards their understanding and management [1-3].

Historical Perspectives: The roots of neuropsychiatry can be traced back to the pioneering work of figures such as Broca, Wernicke, and Charcot, who laid the groundwork for our modern understanding of brain-behavior relationships. Through meticulous anatomical dissections and clinical observations, these early neuropsychiatrists provided invaluable insights into the localization of brain functions and the neuropathological basis of psychiatric symptoms. The advent of technologies such as EEG, CT, and MRI further revolutionized the field, allowing researchers to explore the living brain in unprecedented detail [4].

Current Trends

In the contemporary landscape of neuropsychiatry, there is a growing emphasis on integrating neurobiological findings with clinical practice. Advances in genetics have shed light on the heritable components of psychiatric disorders, paving the way for personalized medicine approaches. Neuroimaging studies have elucidated the neural circuits underlying various mental illnesses, offering new targets for pharmacological and neuromodulatory interventions [5,6]. Moreover, the integration of psychotherapy with neurobiological principles has given rise to novel treatment modalities, such as cognitive-behavioral therapy augmented with neurofeedback techniques.

Challenges and Opportunities

Despite its progress, neuropsychiatry faces several challenges on both theoretical and practical fronts. The complex interplay between genetic, environmental, and psychosocial factors in shaping mental health poses a formidable obstacle to our understanding of psychiatric disorders. Moreover, the heterogeneity of clinical presentations within diagnostic categories complicates efforts to develop universally effective treatments. Nevertheless, these challenges also present opportunities for innovation and collaboration across disciplines. By embracing a philosophy of praxis—a framework that integrates theoretical knowledge with practical application—neuropsychiatry can navigate these challenges and continue to advance the frontiers of mental health research and clinical care [7-10].

Future Directions

Looking ahead, the future of neuropsychiatry holds great promise. Rapid advancements in technology, such as machine learning and optogenetics, offer new tools for unraveling the complexities of the brain. The burgeoning field of precision psychiatry aims to tailor interventions based on individual biomarkers and psychosocial factors, ushering in an era of personalized treatment approaches. Furthermore, the integration of digital health technologies, such as smartphone apps and wearable devices, holds potential for enhancing both assessment and intervention strategies in neuropsychiatric disorders. By embracing innovation, collaboration, and a philosophy of praxis, neuropsychiatry is poised to make significant strides towards improving the lives of individuals affected by mental illness.

Conclusion

In conclusion, neuropsychiatry represents a dynamic and interdisciplinary field that bridges the gap between neuroscience and clinical psychiatry. By integrating theoretical insights with practical applications, neuropsychiatry has the potential to revolutionize our understanding and treatment of mental illness. As we embark on this journey towards a philosophy of praxis, let us remain steadfast in our commitment to advancing the frontiers of neuropsychiatric research and clinical care, with the ultimate goal of promoting mental health and well-being for all.

Acknowledgment

None

Conflict of Interest

None

References

  1. Bestelmeyer PE, Phillips LH, Crombiz C, Benson P, Clair DS (2009) The P300 as a possible endophenotype for schizophrenia and bipolar disorder: Evidence from twin and patient studies. Psychiatry res 169: 212-219.
  2. Google Scholar, Cross Ref, Indexed at

  3. Blasi G, Goldberg TE, Weickert T, Das S, Kohn P, et al. (2006) Brain regions underlying response inhibition and interference monitoring and suppression. Eur J Neurosci 23: 1658-1664.
  4. Google Scholar, Cross Ref, Indexed at

  5. Bleuler E (1958) Dementia praecox or the group of schizophrenias, New York (International Universities Press) 1958.
  6. Google Scholar

  7. Carter CS, Barch DM (2007) Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: the CNTRICS initiative. Schizophr Bull 33: 1131-1137.
  8. Google Scholar, Cross Ref, Indexed at

  9. Chambers CD, Bellgrove MA, Stokes MG, Henderson TR, Garavan H, et al. (2006) Executive “brake failure” following deactivation of human frontal lobe. J Cogn Neurosci 18: 444-455.
  10. Google Scholar, Cross Ref, Indexed at

  11. Aron AR (2011) From reactive to proactive and selective control: developing a richer model for stopping inappropriate responses. Biol psychiatry 69: e55-e68.
  12. Google Scholar, Cross Ref, Indexed at

  13. Badcock JC, Michie PT, Johnson L, Combrinck J (2002) Acts of control in schizophrenia: dissociating the components of inhibition. Psychol Med 32: 287-297.
  14. Google Scholar, Cross Ref, Indexed at

  15. Bannon S, Gonsalvez CJ, Croft RJ, Boyce PM (2002) Response inhibition deficits in obsessive–compulsive disorder. Psychiatry Res 110: 165-174.
  16. Google Scholar, Cross Ref, Indexed at

  17. Bellgrove MA, Chambers CD, Vance A, Hall N, Karamitsios M, et al. (2006) Lateralized deficit of response inhibition in early-onset schizophrenia. Psychol Med 36: 495-505.
  18. Google Scholar, Cross Ref, Indexed at

  19. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP (1992) Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. J Neurosci 12: 924-929.
  20. Google Scholar, Cross Ref, Indexed at

Citation: Soares C (2024) Neuropsychiatry: Towards a Philosophy of Praxis. JNeuroinfect Dis 15: 499. DOI: 10.4172/2314-7326.1000499

Copyright: © 2024 Soares C. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top